Latest filing published 25 Mar 2022 for Oasmia Pharmaceutical AB, €1,959.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Francois-Regis Martelet: trading record in brief
This profile gathers the share dealings of Francois-Regis Martelet in Oasmia Pharmaceutical AB. We count 4 filings; the first trade dates from 13 October 2020 and the latest from 22 March 2022.
Every open-market trade on record is a purchase: 2 purchases worth €20k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
The newest entry dates from 25 March 2022: a transaction of €1,959, in Oasmia Pharmaceutical AB. The latest purchase dates back some time: it was published 1,943 days ago, on 14 July 2021. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Francois-Regis Martelet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,200 shares@ SEK 1.688.9% of flowBTA (betald tecknad aktie)ISIN SE0017564958FI:csv-d42d20478a24d1402be8
- 2,250,000 shares0OptionFI:csv-8baa4f6b0edc2430cb49
- 41,000 shares@ SEK 2.960254.0% of flowAktieISIN SE0000722365FI:csv-7fe5dd015ed235aed1f8Canonical exit: 11 Oct 2021 (T+90)
- 20,000 shares@ SEK 4.25100.0% of flowAktieISIN SE0000722365FI:csv-d3327120bdc42002f77eCanonical exit: 11 Jan 2021 (T+90)
4 of 4 declarations